HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Intravenous application of a primary sevoflurane metabolite improves outcome in murine septic peritonitis: first results.

Abstract
Volatile anesthetics are known to have immunomodulatory effects in conditions of organ injury. A recent study in an experimental sepsis model has shown remarkably improved survival when mice were exposed to volatile anesthetics. In the present study, we show that hexafluoroisopropanol - a water-soluble primary sevoflurane metabolite - has beneficial effects on the overall survival in a murine model of cecal ligation and puncture. Seven-day survival as well as tissue damage markers including transaminases and high mobility group box protein-1 were assessed as measures of end organ damage. In animals undergoing cecal ligation and puncture procedure hexafluoroisopropanol conditioning - but not late postconditioning 24 hours after sepsis induction - significantly increased survival rate (17% vs. 77%, pā€Š=ā€Š0.037) and attenuated secretion of organ damage markers. This study shows survival benefits by administration of the metabolite of a volatile anesthetic. If successfully translated, hexafluoroisopropanol might offer interesting therapeutic opportunities in the future treatment of abdominal sepsis.
AuthorsInge K Herrmann, Maricela Castellon, David E Schwartz, Melanie Hasler, Martin Urner, Guochang Hu, Richard D Minshall, Beatrice Beck-Schimmer
JournalPloS one (PLoS One) Vol. 8 Issue 8 Pg. e72057 ( 2013) ISSN: 1932-6203 [Electronic] United States
PMID23977207 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Biomarkers
  • HMGB1 Protein
  • HMGB1 protein, mouse
  • Immunologic Factors
  • Propanols
  • hexafluoroisopropanol
  • Transaminases
Topics
  • Administration, Intravenous
  • Animals
  • Biomarkers (blood)
  • Blood Urea Nitrogen
  • Cecum (pathology)
  • Drug Evaluation, Preclinical
  • HMGB1 Protein (blood)
  • Immunologic Factors (administration & dosage)
  • Kaplan-Meier Estimate
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Peritonitis (drug therapy, immunology, metabolism)
  • Propanols (administration & dosage)
  • Sepsis (drug therapy, immunology, metabolism)
  • Transaminases (blood)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: